Go Pro
NYSE:DGX

Quest Diagnostics Q3 2026 Earnings Report

Quest Diagnostics logo
$233.63 -11.25 (-4.59%)
As of 10:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Quest Diagnostics EPS Results

Actual EPS
N/A
Consensus EPS
$2.85
Beat/Miss
N/A
One Year Ago EPS
N/A

Quest Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.04 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Quest Diagnostics Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Tuesday, October 20, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Quest Diagnostics Earnings Headlines

MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel
Quest Diagnostics (NYSE:DGX) Given New $260.00 Price Target at Truist Financial
See More Quest Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quest Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your email.

About Quest Diagnostics

Quest Diagnostics (NYSE:DGX) (NYSE: DGX) is a provider of diagnostic information services. The company performs laboratory testing used to help diagnose, monitor and manage diseases and other health conditions, serving physicians, hospitals, health plans, employers, government agencies and individual consumers.

Its services include routine blood and urine testing, advanced and esoteric diagnostics, molecular and genetic testing, anatomic pathology, cancer testing, drug screening and wellness-related assessments. Quest also provides laboratory management and diagnostic support services for hospitals and other healthcare organizations, as well as consumer-ordered testing through its retail and digital channels.

Quest Diagnostics traces its roots to laboratories established by Corning Incorporated and became an independent public company in 1996. The company is headquartered in Secaucus, New Jersey, and primarily serves customers throughout the United States through a network of laboratories, patient service centers and other healthcare partnerships. Quest is led by President and Chief Executive Officer Jim Davis.

View Quest Diagnostics Profile